Papers
1
Total Citations
4
H-Index
1
About
Dr. Yanze Lin is a pioneering urologic surgeon whose research focuses on advancing minimally invasive treatments for renal cancer, particularly through the integration of interventional radiology and robotic surgery. His most cited work, a 2023 study on superselective transarterial embolization (STE) combined with zero ischaemia robotic-assisted laparoscopic partial nephrectomy (RALPN), demonstrates a novel approach to preserving renal function while achieving oncologic control. By retrospectively analyzing 32 patients with T1 renal tumors, Dr. Lin showed that preoperative STE enables safe, bloodless tumor resection without renal artery clamping—a technique that minimizes ischaemic injury to healthy kidney tissue. Though early in its citation trajectory (4 citations), this work has already influenced surgical protocols for nephron-sparing surgery. Dr. Lin’s contributions sit at the intersection of urology and interventional oncology, offering a paradigm shift toward “zero ischaemia” partial nephrectomy. His research underscores a commitment to reducing surgical morbidity while expanding treatment options for renal cell carcinoma, positioning him as an emerging leader in robotic urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1